Answer
Opdualag (nivolumab + relatlimab) must not be infused at the same time as other medicines through the same intravenous line, and must not be mixed with other medicines because compatibility studies are absent.
Sources for this answer
- Opdualag 240 mg/80 mg concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §6.2 Incompatibilities · Version 6Document updated
Sources checked